‹ Screener

DAVITA INC.

DVA · Services-Misc Health & Allied Services, NEC · 64.2M shares · -12%/yr ↓ buyback · EDGAR filings ↗
Net buyback after stock comp: $160M (gross $272M, SBC $112M)

Reference price $209.28 · est. market cap ~$13.4B — last insider sale, 2026-06-16 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)

Grade

B75

DaVita — dominant dialysis provider, highly cash-generative.

Strengths

Risks

Notable findings

Quarterly revenue

2025-06-30 · $3.4B2025-09-30 · $3.4B2025-12-31 · $3.6B2026-03-31 · $3.4B

Last 4 quarters · from SEC filings.

Key metrics

Operating margin
15.0%
Net margin
5.5%
Return on equity
-114.7%
Return on assets
4.3%
Revenue growth (QoQ)
-5.6%
Net-income growth
-20.2%
Current ratio
1.3×
Free cash flow
$1.3B
EBITDA
$2.8B
Tangible book value
-$8.4B
Cash & investments
$742M
Stock comp / revenue
1.0%

Insider transactions · last 18 months

DateInsiderTypeSharesPrice
2026-06-16Rodriguez JavierSell39K$209.28
2026-06-15Rodriguez JavierSell30K$209.50
2026-06-15Waters Kathleen AlyceSell6.5K$209.17
2026-06-15Waters Kathleen AlyceSell8.9K$207.84
2026-05-26YALE PHYLLIS RGift5.0K
2026-05-15Hollar Jason M.Grant250
2026-05-15HEARTY JAMES OSell15K$193.98
2026-05-15Schoppert Wendy LeeGrant250
2026-05-15Arway Pamela MGrant250
2026-05-15YALE PHYLLIS RGrant250
2026-05-15DESOER BARBARA JGrant250
2026-05-15Schechter Adam HGrant250
2026-05-15Pullin Dennis WGrant250
2026-05-15Moore Gregory J.Grant250
2026-05-14HEARTY JAMES ODisposition3.2K$198.10
2026-05-14HEARTY JAMES OTax withheld1.1K$198.10
2026-05-14HEARTY JAMES OOption exercise5.8K$110.63
2026-05-12Maughan David PaulSell13K$199.25
2026-05-11Maughan David PaulSell7.1K$199.15
2026-05-07ACKERMAN JOELSell51K$192.10
2026-05-06HEARTY JAMES OSell2.2K$174.87
2026-03-15HEARTY JAMES OGrant1.1K
2026-03-15HEARTY JAMES OTax withheld769$150.72
2026-03-15HEARTY JAMES OTax withheld9.0K$150.72
2026-03-15HEARTY JAMES OTax withheld300$150.72
2026-03-15HEARTY JAMES OTax withheld1.5K$150.72
2026-03-15Schoppert Wendy LeeGrant332
2026-03-15Waters Kathleen AlyceTax withheld2.5K$150.72
2026-03-15Arway Pamela MGrant332
2026-03-15DESOER BARBARA JGrant332
2026-03-15Maughan David PaulGrant5.3K
2026-03-15Maughan David PaulTax withheld5.3K$150.72
2026-03-15Maughan David PaulTax withheld7.8K$150.72
2026-03-15YALE PHYLLIS RGrant332
2026-03-15Rodriguez JavierGrant21K
2026-03-15Pullin Dennis WGrant332
2026-03-15Hollar Jason M.Grant332
2026-03-15BERRY CHRISTOPHER MICHAELGrant3.6K
2026-03-15ACKERMAN JOELGrant5.7K
2026-03-15ACKERMAN JOELTax withheld3.4K$150.72
2026-03-15ACKERMAN JOELTax withheld34K$150.72
2026-03-15ACKERMAN JOELTax withheld5.8K$150.72
2026-03-15Schechter Adam HGrant332
2026-03-15Moore Gregory J.Grant332
2026-03-15Waters Kathleen AlyceGrant3.2K
2026-03-15Waters Kathleen AlyceTax withheld26K$150.72
2026-03-15Waters Kathleen AlyceTax withheld940$150.72
2026-03-15Waters Kathleen AlyceTax withheld4.3K$150.72
2026-03-10HEARTY JAMES OGrant1.8K
2026-03-10HEARTY JAMES OGrant21K
2026-03-10ACKERMAN JOELGrant6.6K
2026-03-10ACKERMAN JOELGrant66K
2026-03-10Waters Kathleen AlyceGrant4.8K
2026-03-10Waters Kathleen AlyceGrant51K
2026-02-06Waters Kathleen AlyceOption exercise8.1K$108.93
2026-02-06Waters Kathleen AlyceDisposition5.9K$149.22
2026-02-06Waters Kathleen AlyceTax withheld817$149.22
2026-02-06ACKERMAN JOELOption exercise44K$108.93
2026-02-06ACKERMAN JOELDisposition32K$149.22
2026-02-06ACKERMAN JOELTax withheld5.1K$149.22
2025-12-04HEARTY JAMES OOption exercise5.9K$108.93
2025-12-04HEARTY JAMES ODisposition5.4K$118.25
2025-12-04HEARTY JAMES OTax withheld203$118.25
2025-11-15YALE PHYLLIS RGrant411
2025-11-15Schoppert Wendy LeeGrant411
2025-11-15Schechter Adam HGrant411
2025-11-15Pullin Dennis WGrant411
2025-11-15Moore Gregory J.Grant411
2025-11-15Hollar Jason M.Grant411
2025-11-15DESOER BARBARA JGrant411
2025-11-15Arway Pamela MGrant411
2025-11-15Rodriguez JavierTax withheld5.2K$121.55
2025-09-22Maughan David PaulTax withheld7.5K$130.16
2025-08-15Pullin Dennis WGrant369
2025-08-15Schoppert Wendy LeeGrant369
2025-08-15Arway Pamela MGrant369
2025-08-15Moore Gregory J.Grant369
2025-08-15Hollar Jason M.Grant369
2025-08-15DESOER BARBARA JGrant369
2025-08-15Schechter Adam HGrant369
2025-08-15YALE PHYLLIS RGrant369
2025-07-23HEARTY JAMES OSell2.4K$150.00
2025-05-15Schechter Adam HGrant348
2025-05-15DESOER BARBARA JGrant348
2025-05-15Hollar Jason M.Grant348
2025-05-15Arway Pamela MGrant348
2025-05-15Pullin Dennis WGrant348
2025-05-15Schoppert Wendy LeeGrant348
2025-05-15YALE PHYLLIS RGrant348
2025-05-15BERG CHARLESGrant348
2025-05-15Moore Gregory J.Grant348
2025-03-15Schoppert Wendy LeeGrant349
2025-03-15Maughan David PaulGrant5.2K
2025-03-15Maughan David PaulTax withheld5.0K$143.45
2025-03-15Maughan David PaulTax withheld4.3K$143.45
2025-03-15ACKERMAN JOELGrant6.0K
2025-03-15ACKERMAN JOELTax withheld3.1K$143.45
2025-03-15ACKERMAN JOELTax withheld3.3K$143.45
2025-03-15Schechter Adam HGrant349
2025-03-15Waters Kathleen AlyceTax withheld2.8K$143.45
2025-03-15Rodriguez JavierGrant19K
2025-03-15HEARTY JAMES OGrant1.2K
2025-03-15HEARTY JAMES OTax withheld866$143.45
2025-03-15HEARTY JAMES OTax withheld846$143.45
2025-03-15HEARTY JAMES OTax withheld306$143.45
2025-03-15HEARTY JAMES OTax withheld301$143.45
2025-03-15Pullin Dennis WGrant349
2025-03-15Moore Gregory J.Grant349
2025-03-15BERRY CHRISTOPHER MICHAELGrant3.8K
2025-03-15Hollar Jason M.Grant349
2025-03-15BERG CHARLESGrant349
2025-03-15Arway Pamela MGrant349
2025-03-15YALE PHYLLIS RGrant349
2025-03-15Waters Kathleen AlyceGrant3.3K
2025-03-15Waters Kathleen AlyceTax withheld2.7K$143.45
2025-03-15Waters Kathleen AlyceTax withheld955$143.45
2025-03-15Waters Kathleen AlyceTax withheld939$143.45
2025-03-15DESOER BARBARA JGrant349
2025-03-12ACKERMAN JOELGrant7.4K
2025-03-12ACKERMAN JOELGrant7.2K
2025-03-12HEARTY JAMES OGrant1.9K
2025-03-12Waters Kathleen AlyceGrant5.4K
2025-03-12Waters Kathleen AlyceGrant5.3K
2025-03-12HEARTY JAMES OGrant2.0K
2025-03-03HEARTY JAMES OOption exercise4.6K$75.95
2025-03-03HEARTY JAMES ODisposition2.4K$147.88
2025-03-03HEARTY JAMES OTax withheld674$147.88

All non-derivative Form 4 activity (SEC), newest first.

Clinical trials

TrialTitlePhaseStatusPrimary completion
NCT01623583 ↗Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias
Needle Phobia, Phobic Disorders
PHASE4Terminated2015-03-01

Source: ClinicalTrials.gov (U.S. NIH) · active studies first.

Supply chain

Customers (0)

    Named in the 10-K; linked when we track them.

    Notable events (8-K)

    DateItems
    2026-06-08Material agreementDebt obligationShareholder voteExhibitsfiling ↗
    2026-05-05ResultsExhibitsfiling ↗
    2026-02-02ResultsExhibitsfiling ↗
    2025-11-25Material agreementDebt obligationExhibitsfiling ↗
    2025-10-29ResultsExhibitsfiling ↗
    2025-08-20Otherfiling ↗
    2025-08-05ResultsExhibitsfiling ↗
    2025-07-17Material agreementDebt obligationExhibitsfiling ↗

    Recent filings

    FormFiledPeriodAccession
    8-K2026-06-082026-06-040001206774-26-000316 ↗
    8-K2026-05-052026-05-050000927066-26-000060 ↗
    10-Q2026-05-052026-03-310000927066-26-000062 ↗
    10-K2026-02-112025-12-310000927066-26-000012 ↗
    8-K2026-02-022026-02-020000927066-26-000004 ↗
    8-K2025-11-252025-11-240001206774-25-000750 ↗
    8-K2025-10-292025-10-290000927066-25-000163 ↗
    10-Q2025-10-292025-09-300000927066-25-000165 ↗
    8-K2025-08-202025-08-200000927066-25-000154 ↗
    8-K2025-08-052025-08-050000927066-25-000122 ↗
    10-Q2025-08-052025-06-300000927066-25-000124 ↗
    8-K2025-07-172025-07-170001193125-25-160501 ↗